DRUG · Unmapped registry intervention
HS-10241
Find medicine records ·
Find other trials using this name
Clinical trial
Pharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function
NCT06823245
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedPharmacokinetic Study of HS-10241 Tablets in Subjects with Hepatic Impairment and Normal Hepatic Function
Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Non-small Cell Lung Cancerunresolved
Interventions
HS-10241DRUG
Sponsors & collaborators
Jiangsu Hansoh Pharmaceutical Co., Ltd.lead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06823245 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.